The Fatty Amides Market, estimated at USD 428.6 Mn in 2025, is expected to exhibit a CAGR of 4.3% and reach USD 575.5 Mn by 2032.
The market growth is driven by rising demand for innovative and efficient solutions, coupled with evolving consumer preferences and increasing adoption across diverse end-use sectors. Technological advancements, product innovations, and strategic investments are enhancing performance, improving cost efficiency, and expanding application scope. Additionally, supportive regulatory frameworks and sustainability-focused initiatives are further propelling market expansion, creating new opportunities for industry stakeholders.
In May 2022, Kao Corporation announced plans to build a new tertiary amine production plant in Texas, U.S. with an annual production capacity of 20,000 tons.
Kao Corporation is a Japanese global chemical and cosmetics company headquartered in Nihonbashi-Kayabacho, Chūō, Tokyo, Japan. Kao Corporation operates in the personal care and cosmetics industry, with a focus on creating products that contribute to a more sustainable world. The company's business regions include the Americas, Europe, Africa, and the Middle East, and it has a strong global presence. Kao Corporation is known for its commitment to environmental, social, and governance (ESG) initiatives and its efforts to promote healthy, inclusive, and sustainable lifestyles.
Fatty Amides Market– Impact of Coronavirus (COVID-19) Pandemic.
The World Health Organization (WHO) designated the illness caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), which first appeared in Wuhan (province of Hubei, China) in the last months of 2019 as "coronavirus disease 2019" or COVID-19. This virus spread quickly and had a serious negative impact on the economies, social behaviors, and healthcare of every country in the world.
COVID-19 affected the economy in three main ways: by directly affecting production and demand, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to the lockdown, several countries, such as India, China, Brazil, and others, faced problems with regard to the transportation of drugs from one place to another.
The spread of the virus and the associated lockdowns led to interruptions in the global supply chain. This affected the availability of raw materials required for the production of fatty amides and also impacted the distribution channels to move finished products to the market.
The demand for fatty amides saw fluctuations depending on their end-use applications. For instance, the demand from end-user industries like automotive and textiles declined due to reduced consumer spending and economic slowdown. However, there may have been stable or increased demand in industries such as pharmaceuticals or personal care, which experienced heightened consumer interest during the pandemic.